Compression treatment in acute symptomatic proximal deep venous thrombosis - Results of a worldwide survey.

Deep venous thrombosis compression post-thrombotic syndrome symptoms treatment

Journal

Phlebology
ISSN: 1758-1125
Titre abrégé: Phlebology
Pays: England
ID NLM: 9012921

Informations de publication

Date de publication:
Aug 2021
Historique:
pubmed: 23 3 2021
medline: 24 8 2021
entrez: 22 3 2021
Statut: ppublish

Résumé

The aim of this study was to illustrate how compression is performed worldwide in proximal DVT and if compression management has changed recently. A global online survey, consisting of 36 questions, was used. The survey was solicited from membership lists of Union Internationale de Phlébologie (UIP) membership societies. For differences between the continents in comparison to Western Europe odds ratios and 95% Confidence Intervals (95%CI) where calculated. We received 626 answers from 41 countries. Compression is routinely used in proximal DVT in all regions (82.8%). 81.4% start compression immediately after diagnosis. In the acute phase of DVT reduction of pain and swelling (91.7%) and PTS prevention (66.2%) are the main reasons for compression. 33.2% recently changed their compression management with 43.5% starting compression earlier and 7.0% later. Compression is still used routinely in proximal DVT in addition to anticoagulation. The changes in international guidelines towards the non-routine use of compression in proximal DVT have not caused significant changes in DVT management.

Identifiants

pubmed: 33745366
doi: 10.1177/02683555211003801
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

526-534

Auteurs

Daniel Rabe (D)

Department of Dermatology and Allergology (promotional student), University of Bonn, Bonn, Germany.

Hugo Partsch (H)

Department of Dermatology (Emeritus) Medical University of Vienna, Vienna, Austria.

Gerhard Heidl (G)

Department of Dermatology and Allergology, University of Bonn, Bonn, Germany.

Mirko Hirschl (M)

Privatklinik Confraternität, Wien, Austria.

Michael Kundi (M)

Medizinische Universität Wien, Zentrum für Public Health, Abteilung für Umwelthygiene und Umweltmedizin, Wien, Austria.

Eberhard Rabe (E)

Department of Dermatology and Allergology (Emeritus), University of Bonn, Bonn, Germany.

Felizitas Pannier (F)

Private Practice Phlebology & Dermatology, Bonn, Germany and Department of Dermatology, University of Cologne, Köln, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH